<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Hepatol</journal-id><journal-id journal-id-type="iso-abbrev">Int J Hepatol</journal-id><journal-id journal-id-type="publisher-id">IJH</journal-id><journal-title-group><journal-title>International Journal of Hepatology</journal-title></journal-title-group><issn pub-type="ppub">2090-3448</issn><issn pub-type="epub">2090-3456</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27293900</article-id><article-id pub-id-type="pmc">4879230</article-id><article-id pub-id-type="doi">10.1155/2016/4030476</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Study</subject></subj-group></article-categories><title-group><article-title>The Effect of Artichoke Leaf Extract on Alanine Aminotransferase and Aspartate Aminotransferase in the Patients with Nonalcoholic Steatohepatitis </article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rangboo</surname><given-names>Vajiheh</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Noroozi</surname><given-names>Mostafa</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Zavoshy</surname><given-names>Roza</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Rezadoost</surname><given-names>Seyed Amirmansoor</given-names></name><xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Mohammadpoorasl</surname><given-names>Asghar</given-names></name><xref ref-type="aff" rid="I5">
<sup>5</sup>
</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Department of Nutrition, Faculty of Health, Qazvin University of Medical Sciences, Qazvin, Iran</aff><aff id="I2"><sup>2</sup>Children Growth Research Center, Qazvin University of Medical Sciences, Qazvin, Iran</aff><aff id="I3"><sup>3</sup>Department of Nutrition, Faculty of Nutrition, Qazvin University of Medical Sciences, Qazvin, Iran</aff><aff id="I4"><sup>4</sup>Shahid Chamran Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran</aff><aff id="I5"><sup>5</sup>Department of Epidemiology, Tabriz University of Medical Sciences, Tabriz, Iran</aff><author-notes><corresp id="cor1">*Mostafa Noroozi: <email>mnoroozi@ymail.com</email></corresp><fn fn-type="other"><p>Academic Editor: Roberto Lupi</p></fn></author-notes><pub-date pub-type="ppub"><year>2016</year></pub-date><pub-date pub-type="epub"><day>11</day><month>5</month><year>2016</year></pub-date><volume>2016</volume><elocation-id>4030476</elocation-id><history><date date-type="received"><day>11</day><month>10</month><year>2015</year></date><date date-type="rev-recd"><day>22</day><month>2</month><year>2016</year></date><date date-type="accepted"><day>10</day><month>3</month><year>2016</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2016 Vajiheh Rangboo et al.</copyright-statement><copyright-year>2016</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>
<italic>Background</italic>. Based on recent basic and clinical investigations, the extract of artichoke (<italic>Cynara scolymus</italic>) leaf has been revealed to be used for hepatoprotective and cholesterol reducing purposes. We aimed to assess the therapeutic effects of artichoke on biochemical and liver biomarkers in patients with nonalcoholic steatohepatitis (NASH).<italic> Methods</italic>. In a randomized double blind clinical trial, 60 consecutive patients suffering NASH were randomly assigned to receive<italic> Cynara scolymus</italic> extract (as 6 tablets per day consisting of 2700&#x02009;mg extract of the herb) as the intervention group or placebo as the control group for two months.<italic> Results</italic>. Comparing changes in study markers following interventions showed improvement in liver enzymes. The levels of triglycerides and cholesterol were significantly reduced in the group treated with<italic> Cynara scolymus</italic> when compared to placebo group. To compare the role of<italic> Cynara scolymus</italic> use with placebo in changes in study parameters, multivariate linear regression models were employed indicating higher improvement in liver enzymes and also lipid profile particularly triglycerides and total cholesterol following administration of<italic> Cynara scolymus</italic> in comparison with placebo use.<italic> Conclusion</italic>. This study sheds light on the potential hepatoprotective activity and hypolipidemic effect of<italic> Cynara scolymus</italic> in management of NASH. This clinical trial is registered in the IRCT, Iranian Registry of Clinical Trials, by number <ext-link ext-link-type="uri" xlink:href="http://en.search.irct.ir/view/18981">IRCT2014070218321N1</ext-link>.</p></abstract></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Nonalcoholic fatty liver disease (NAFLD) refers to a wide spectrum of disorders characterized by fatty infiltration in the liver and steatosis [<xref rid="B1" ref-type="bibr">1</xref>]. By developing oxidative stress, hepatocellular inflammation, and steatosis, the term was replaced by nonalcoholic steatohepatitis (NASH) that may culminate in cirrhosis and hepatocellular carcinoma [<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>]. Within the last decade, prevalence of NASH has interestingly doubled especially in the Middle East, Far East, Africa, the Caribbean, and Latin America due to its close association with lifestyle disorders such as diabetes and obesity [<xref rid="B4" ref-type="bibr">4</xref>]. In this regard, the best treatment approaches for this phenomenon include weight loss, changes in dietary regimens, and lifestyle modifications. Also, in cases with documented hyperlipidemia or diabetes, use of insulin sensitizing and lipid lowering drugs can be also considered [<xref rid="B5" ref-type="bibr">5</xref>]. However, since NASH is a multifactorial disorder, single target based therapy has limited implications. Hence, the use of herbal medicine approach can be a promising alternative due to its multipronged mechanisms of action [<xref rid="B6" ref-type="bibr">6</xref>&#x02013;<xref rid="B8" ref-type="bibr">8</xref>].</p><p>Artichoke (<italic>Cynara scolymus</italic>) is a plant frequently grown in Mediterranean countries that is rich in natural antioxidants and thus is used as a herbal drug [<xref rid="B9" ref-type="bibr">9</xref>]. Based on recent basic and clinical investigations, the extract of artichoke leaf has been revealed to be used for hepatoprotective [<xref rid="B10" ref-type="bibr">10</xref>&#x02013;<xref rid="B12" ref-type="bibr">12</xref>], antimicrobial [<xref rid="B13" ref-type="bibr">13</xref>], and cholesterol reducing purposes [<xref rid="B14" ref-type="bibr">14</xref>].</p><p>Artichoke has been found to decrease the production of reactive oxygen species, the oxidation of low-density lipoproteins [<xref rid="B15" ref-type="bibr">15</xref>], lipid peroxidation [<xref rid="B11" ref-type="bibr">11</xref>], and protein oxidation and increase the activity of glutathione peroxidase [<xref rid="B16" ref-type="bibr">16</xref>]. In this regard, it seems that the use of this herb may be promising to treat NASH. The present study aimed to assess the therapeutic effects of artichoke on biochemical and liver biomarkers in patients with NASH.</p></sec><sec id="sec2"><title>2. Subjects and Methods</title><sec id="sec2.1"><title>2.1. Study Population</title><p>In a randomized double blind clinical trial, 60 consecutive patients who suffered NASH (based on changes in liver enzymes and sonographic evidences) were included in the study. The main inclusion criteria were elevation of liver enzymes (&#x0003e;30&#x02009;<italic>&#x003bc;</italic>/L), any evidences of fatty liver in abdominal sonography, and the existence of at least one of these characteristics: total cholesterol &#x0003e; 200&#x02009;mg/dL, high density lipoprotein (HDL) &#x0003c; 40&#x02009;mg/dL for men and &#x0003c;50&#x02009;mg/dL for women, serum triglycerides level &#x0003e; 150&#x02009;mg/dL, fasting blood sugar &#x0003e; 100&#x02009;mg/dL, obesity defined as body mass index &#x0003e; 30&#x02009;kg/m<sup>2</sup>, or blood pressure &#x0003e; 130/85&#x02009;mmHg. In this regard, the main exclusion criteria were daily alcohol consumption, diabetes mellitus type I, the existence of concomitant liver diseases such as hepatitis B or C, autoimmune hepatitis, Wilson, hemochromatosis, alpha-1 antitrypsin deficiency, or biliary obstruction, the use of vitamin C, livergol, hepatotoxic drugs, NASH inducing drugs such as amiodarone, calcium-channel blockers, or tamoxifen, pregnancy or breastfeeding, sensitivity to artichoke species, or any life-threatening disorders.</p><p>The two groups were matched in terms of sex distribution (21 male and 9 female in both groups) and mean age (47.27 &#x000b1; 8.12 years in intervention group and 49.83 &#x000b1; 12.79 years in placebo group, <italic>P</italic> = 0.357). The two groups were also similar in other baseline characteristics including weight, levels of liver enzymes, lipid profile, and fasting blood sugar on initial assessment.</p></sec><sec id="sec2.2"><title>2.2. Study Intervention</title><p>The baseline characteristics of patients were collected by interviewing and the study questionnaires were recorded. The patients were then randomly assigned to receive<italic> Cynara scolymus</italic> extract (as 6 tablets per day consisting of 2700&#x02009;mg extract of the herb prepared in Dineh company, Qazvin, Iran) as the intervention group or placebo as the control group for two months (placebo was prepared from the same ingredient as treatment except<italic> Cynara scolymus</italic> extract). The randomization was done using computer generated random number tables. Both groups were advised to maintain regular physical activity (20&#x02009;min walking within 5 days a week) and an appropriate dietary regimen (calculated based on patients' weight, height, age, and percentage of activity using the Mifflin formula to gradually reduce body weight).</p></sec><sec id="sec2.3"><title>2.3. Measurement of Biomarkers</title><p>Serum alanine transaminase (ALT) and aspartate transaminase (AST) activity was estimated colorimetrically using an especial kit (Pars Azmoon company, Iran) according to the method of Reitman and Frankel [<xref rid="B17" ref-type="bibr">17</xref>]. Serum cholesterol (Chol) concentration was determined colorimetrically using an especial kit (Pars Man company, Iran) according to the method of Allain et al. [<xref rid="B18" ref-type="bibr">18</xref>]. Serum LDL-cholesterol (LDL) concentration was assayed colorimetrically using an especial kit (Pars Azmoon company, Iran) according to the method of Assmann et al. [<xref rid="B19" ref-type="bibr">19</xref>]. Serum HDL-cholesterol (HDL) concentration was measured colorimetrically using an especial kit (Pars Man company, Iran) according to the method of Lopez-Virella et al. [<xref rid="B20" ref-type="bibr">20</xref>]. Serum triglycerides (TG) level was determined colorimetrically using an especial kit (Pars Azmoon company, Iran) according to the method of Fassati and Prencipe [<xref rid="B21" ref-type="bibr">21</xref>]. The biomarkers were measured at the two time points: admission time and 2 months after the initial assessment (completing treatment protocols).</p></sec><sec id="sec2.4"><title>2.4. Statistical Analysis</title><p>Results were presented as mean &#x000b1; standard deviation (SD). Continuous variables were compared using <italic>t</italic>-test or nonparametric Mann-Whitney <italic>U</italic> test. The changes in study biomarkers after interventions were assessed using the Paired <italic>t</italic>-test or nonparametric Wilcoxon test. The multivariate linear regression analysis was used for assessing study outcomes following different employed protocols as follows. First, the baseline variables as probable confounders with a <italic>P</italic> value &#x0003c;0.20 in univariate analyses were taken in a multivariate logistic regression model to assess the difference between the treatment groups receiving<italic> Cynara scolymus</italic> extract or placebo with the presence of these confounders. For the statistical analysis, the statistical software SPSS version 21.0 for windows (SPSS Inc., Chicago, IL) was used.</p></sec></sec><sec id="sec3"><title>3. Results</title><p>As shown in <xref ref-type="table" rid="tab1">Table 1</xref>, following administration of<italic> Cynara scolymus</italic>, significant reduction was observed in mean weight, as well as in serum levels of ALT, AST, blood sugar, total cholesterol, LDL, and triglycerides. Also, mean systolic blood pressure was significantly reduced using<italic> Cynara scolymus</italic>. In contrast, using placebo resulted in significant reduction in mean weight, as well as in serum levels of ALT and AST; however, among other biomarkers, blood sugar and lipid profile remained unchanged. Comparing changes in study markers following interventions showed the changes in liver enzymes, and also levels of triglycerides and cholesterol were significantly more in group treated with<italic> Cynara scolymus</italic> when compared to placebo group (<xref ref-type="table" rid="tab2">Table 2</xref>). To compare the role of<italic> Cynara scolymus</italic> use with placebo in changes in study parameters, multivariate linear regression models were employed (<xref ref-type="table" rid="tab2">Table 2</xref>) indicating higher improvement in liver enzymes and also lipid profiles of triglycerides and total cholesterol following administration of<italic> Cynara scolymus</italic> in comparison with placebo use.</p></sec><sec id="sec4"><title>4. Discussion</title><p>Our study aimed to assess the beneficial effects of<italic> Cynara scolymus,</italic> a herb with antioxidant compounds, on liver function and also lipid profile and fasting blood glucose. On the other hand, we aimed to demonstrate therapeutic effects of this herb on liver functional biomarkers and also hemodynamic parameters in patients with NASH. In this double blind clinical trial, patients in intervention group received<italic> Cynara scolymus</italic> extract for two months and changes in study biomarkers were reassessed.</p><p>Serum ALT and AST are effective biomarkers in the diagnosis of hepatic damage. Sever liver damage was demonstrated by remarkable elevation of serum ALT and AST levels. This elevation may be attributed to the release of these enzymes from the cytoplasm in to the blood circulation after rupture of the plasma membrane and cellular damage [<xref rid="B22" ref-type="bibr">22</xref>].</p><p>The result of the present study showed significant changes in serum ALT and AST levels in intervention group in comparison with the placebo group (<italic>P</italic> &#x0003c; 0.001). This effect could be attributed to the antioxidant ingredients in<italic> Cynara scolymus</italic> extract such as mono- and dicaffeoylquinic acid (cynarin and chlorogenic acid), caffeic acid and flavonoids including the glycosides luteolin-7-<italic>&#x003b2;</italic>-rutinoside (scolymoside), luteolin-7-<italic>&#x003b2;</italic>-D-glucoside, and luteolin-4-<italic>&#x003b2;</italic>-D-glucoside that are mainly compounds in<italic> Cynara scolymus</italic> extract [<xref rid="B23" ref-type="bibr">23</xref>&#x02013;<xref rid="B25" ref-type="bibr">25</xref>]. And chlorogenic acid is the most active antioxidant in<italic> Cynara scolymus</italic> extract [<xref rid="B26" ref-type="bibr">26</xref>]. Antioxidants are components that prevent oxidative reactions often by scavenging free radicals before they can damage cells [<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>]. Several in vitro and animal studies assessed the antioxidative and free radical scavenging potential of artichoke extracts in protection hepatocytes from oxidative stress [<xref rid="B29" ref-type="bibr">29</xref>&#x02013;<xref rid="B32" ref-type="bibr">32</xref>], but there are a few human and clinical studies in this regard. The result of the present study in reduction of serum ALT and AST levels is in agreement with Saffa et al. They investigate the efficacy of<italic> Cynara scolymus </italic>total methanolic extract (CSM) and its fraction (CSF) in rat. Their result showed that CSF is more active in comparison with CSM. Perhaps it is because of high concentration of monocaffeoylquinic acid derivatives (chlorogenic acid) in CSF [<xref rid="B33" ref-type="bibr">33</xref>]. In Huber's study although the used doses of<italic> Cynara scolymus</italic> extract and duration of study were more than the present study, remarkable reduction in serum ALT and AST levels was not seen in patients with hepatitis C, which is not in agreement with our study. It appears that because of microbial agent and sever damage of hepatocytes uneffectiveness of<italic> Cynara scolymus </italic>extract on ALT and AST was caused [<xref rid="B34" ref-type="bibr">34</xref>]. Also, in present study, improvement of lipid profile was significantly observed in the group receiving<italic> Cynara scolymus</italic> extract not in placebo group. These effects could be attributed to active ingredients in<italic> Cynara scolymus</italic> extract which are known as caffeoylquinic acid derivatives (cynarin and chlorogenic acid). Some previous studies showed that these compounds can reduce cholesterol by inhibiting HMG-COA reductase and having a hypolipidemic influence lowering blood cholesterol [<xref rid="B26" ref-type="bibr">26</xref>].</p><p>Our result on hypocholesterolemic effect of<italic> Cynara scolymus</italic> extract is in agreement with Pittler et al. [<xref rid="B35" ref-type="bibr">35</xref>]. Some studies suggest that<italic> Cynara scolymus</italic> extract reduces blood lipids by directly influencing biosynthesis of cholesterol and also by production and secretion of bile from the liver [<xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B37" ref-type="bibr">37</xref>]. Reduction in triglycerides level is attributed to improvement in glycemic control and reduction of glucose instead of fat. Acetyl COA yield from pyruvic acid enters Krebs cycle and leads to metabolism of glucose completely instead of triglycerides biosynthesis.</p><p>In present study improvement in fasting blood sugar was significantly observed in group receiving<italic> Cynara scolymus</italic> extract not in placebo group. This beneficial effect could be attributed to high antioxidant capacity of this herb. Phenolic compounds, specially, such as caffeic acid and flavonoids, are representative of this effect.</p><p>Another mechanism for reducing glucose level by<italic> Cynara scolymus</italic> extract is affecting glucose absorption. Antioxidant compounds delay depletion of stomach and bowels and they inhibited <italic>&#x003b1;</italic>-amylase and <italic>&#x003b1;</italic>-glucosidase enzymes in bowels and blocked glucose transportation to blood. On the other hand antioxidants have insulin-like effect and increase glucose absorption in peripheral tissue. Another probable mechanism is influencing <italic>&#x003b2;</italic>-cells, repairing damage cells, and stimulating these cells to secrete insulin. Studies show that chlorogenic acid has antidiabetic effect [<xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B39" ref-type="bibr">39</xref>] and reduction glucose by reason of this compound.</p><p>Another point of this study was the parallel improvement in liver enzymes and also lipid profile by administrating<italic> Cynara scolymus</italic> that was not simultaneously in placebo group. Cholesterol metabolism is associated with liver fat content independent of body weight, implying that the more the fat the liver contains, the higher the cholesterol synthesis is [<xref rid="B40" ref-type="bibr">40</xref>]. Cellular cholesterol synthesis is regulated by activation of membrane bound transcription factors, designated sterol regulatory element-binding proteins (SREBPs) which are the most abundant in the liver [<xref rid="B41" ref-type="bibr">41</xref>], and the excess of cellular cholesterol is esterified by the acyl CoA-cholesterol acyltransferase (ACAT) [<xref rid="B42" ref-type="bibr">42</xref>]. The high level of cholesterol synthesis and the increased SREBP-2 activity have paradoxically been shown in subjects with NASH [<xref rid="B43" ref-type="bibr">43</xref>]. It is thus suggested that the effects of<italic> Cynara scolymus</italic> may appear by inducing and involving these metabolic pathways in the liver.</p><p>The main strength of the study was to shed light on the potential role of artichoke on biochemical and liver biomarkers in patients with NASH in a controlled trial. Although, in previous studies, the role of this herb to treat NASH has been assessed, a few studies focused directly on the improvement of liver enzymes<italic> via</italic> administrating this herbal drug. Another strength of the current study was to assess the simultaneous changes in liver enzymes, blood sugar, and lipid profile. This concomitant assessment is important because the central role of liver leads to metabolic pathways regulating the level of these metabolic biomarkers. However, our study had some potential limitations including small sample size leading to partially low study power as well as ignoring other baseline clinical and pharmacological confounders affecting the employed regression models used for assessing the effects of artichoke on biochemical and liver biomarkers in NASH.</p></sec><sec id="sec5"><title>5. Conclusion</title><p>In conclusion, the current study sheds light on the potential role of<italic> Cynara scolymus</italic> in management of NASH. The active constituents of this herb such as flavonoids and caffeoylquinic acid may be responsible for this effect. These compounds have been proven to have hepatoprotective activity and hypolipidemic effect.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors would like to thank Children Growth Research Center, Qazvin University of Medical Sciences, Qazvin, Iran, and Deputy of Research, Qazvin University of Medical and Health Sciences, Qazvin, Iran, for financial support (Grant no. D.44.7929). Thanks are due to the mothers who participated in their study. They would also like to thank the health care staff for cooperation in collecting the data and thank Dineh company for providing the extract of artichoke leaf and placebo.</p></ack><sec><title>Ethical Approval</title><p>The protocol was approved by the Research Council and Ethical Committee of Qazvin University of Medical Sciences, no. D28/20/7929.</p></sec><sec><title>Consent</title><p>Consent was obtained from each patient. They could quit the study freely. All participants provided informed written consent.</p></sec><sec><title>Competing Interests</title><p>The authors have no competing interests.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chalasani</surname><given-names>N.</given-names></name><name><surname>Younossi</surname><given-names>Z.</given-names></name><name><surname>Lavine</surname><given-names>J. E.</given-names></name><etal/></person-group><article-title>The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology</article-title><source><italic>Gastroenterology</italic></source><year>2012</year><volume>142</volume><issue>7</issue><fpage>1592</fpage><lpage>1609</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2012.04.001</pub-id><pub-id pub-id-type="other">2-s2.0-84861591910</pub-id><pub-id pub-id-type="pmid">22656328</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dyson</surname><given-names>J. K.</given-names></name><name><surname>Anstee</surname><given-names>Q. M.</given-names></name><name><surname>McPherson</surname><given-names>S.</given-names></name></person-group><article-title>Non-alcoholic fatty liver disease: a practical approach to treatment</article-title><source><italic>Frontline Gastroenterology</italic></source><year>2014</year><volume>5</volume><issue>4</issue><fpage>277</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1136/flgastro-2013-100404</pub-id><pub-id pub-id-type="pmid">25285192</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machado</surname><given-names>M. V.</given-names></name><name><surname>Cortez-Pinto</surname><given-names>H.</given-names></name></person-group><article-title>Non-alcoholic fatty liver disease: what the clinician needs to know</article-title><source><italic>World Journal of Gastroenterology</italic></source><year>2014</year><volume>20</volume><issue>36</issue><fpage>12956</fpage><lpage>12980</lpage><pub-id pub-id-type="doi">10.3748/wjg.v20.i36.12956</pub-id><pub-id pub-id-type="other">2-s2.0-84925535551</pub-id><pub-id pub-id-type="pmid">25278691</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corrado</surname><given-names>R. L.</given-names></name><name><surname>Torres</surname><given-names>D. M.</given-names></name><name><surname>Harrison</surname><given-names>S. A.</given-names></name></person-group><article-title>Review of treatment options for nonalcoholic fatty liver disease</article-title><source><italic>Medical Clinics of North America</italic></source><year>2014</year><volume>98</volume><issue>1</issue><fpage>55</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/j.mcna.2013.09.001</pub-id><pub-id pub-id-type="other">2-s2.0-84888027087</pub-id><pub-id pub-id-type="pmid">24266914</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eguchi</surname><given-names>A.</given-names></name><name><surname>Povero</surname><given-names>D.</given-names></name><name><surname>Alkhouri</surname><given-names>N.</given-names></name><name><surname>Feldstein</surname><given-names>A. E.</given-names></name></person-group><article-title>Novel therapeutic targets for nonalcoholic fatty liver disease</article-title><source><italic>Expert Opinion on Therapeutic Targets</italic></source><year>2013</year><volume>17</volume><issue>7</issue><fpage>773</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1517/14728222.2013.789502</pub-id><pub-id pub-id-type="other">2-s2.0-84879055120</pub-id><pub-id pub-id-type="pmid">23600493</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uhl</surname><given-names>P.</given-names></name><name><surname>Fricker</surname><given-names>G.</given-names></name><name><surname>Haberkorn</surname><given-names>U.</given-names></name><name><surname>Mier</surname><given-names>W.</given-names></name></person-group><article-title>Current status in the therapy of liver diseases</article-title><source><italic>International Journal of Molecular Sciences</italic></source><year>2014</year><volume>15</volume><issue>5</issue><fpage>7500</fpage><lpage>7512</lpage><pub-id pub-id-type="doi">10.3390/ijms15057500</pub-id><pub-id pub-id-type="other">2-s2.0-84899754104</pub-id><pub-id pub-id-type="pmid">24786290</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mouzaki</surname><given-names>M.</given-names></name><name><surname>Allard</surname><given-names>J.</given-names></name></person-group><article-title>Non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic</article-title><source><italic>Annals of Gastroenterology</italic></source><year>2012</year><volume>25</volume><issue>3</issue><fpage>207</fpage><lpage>217</lpage><pub-id pub-id-type="other">2-s2.0-84863479772</pub-id><pub-id pub-id-type="pmid">24713803</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jadeja</surname><given-names>R.</given-names></name><name><surname>Devkar</surname><given-names>R. V.</given-names></name><name><surname>Nammi</surname><given-names>S.</given-names></name></person-group><article-title>Herbal medicines for the treatment of nonalcoholic steatohepatitis: current scenario and future prospects</article-title><source><italic>Evidence-Based Complementary and Alternative Medicine</italic></source><year>2014</year><volume>2014</volume><fpage>18</fpage><pub-id pub-id-type="publisher-id">648308</pub-id><pub-id pub-id-type="doi">10.1155/2014/648308</pub-id><pub-id pub-id-type="other">2-s2.0-84903625011</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulinacci</surname><given-names>N.</given-names></name><name><surname>Prucher</surname><given-names>D.</given-names></name><name><surname>Peruzzi</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Commercial and laboratory extracts from artichoke leaves: estimation of caffeoyl esters and flavonoidic compounds content</article-title><source><italic>Journal of Pharmaceutical and Biomedical Analysis</italic></source><year>2004</year><volume>34</volume><issue>2</issue><fpage>349</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1016/s0731-7085(03)00552-1</pub-id><pub-id pub-id-type="other">2-s2.0-0842309040</pub-id><pub-id pub-id-type="pmid">15013149</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>A. Y.</given-names></name><name><surname>Foster</surname><given-names>S.</given-names></name></person-group><source><italic>Encyclopedia of Common Natural Ingredients Used in Food. Drugs and Cosmetics</italic></source><year>1996</year><edition>2nd</edition><publisher-loc>New York, NY, USA</publisher-loc><publisher-name>John Wiley &#x00026; Sons</publisher-name></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Newall</surname><given-names>C. A.</given-names></name><name><surname>Anderson</surname><given-names>L. A.</given-names></name><name><surname>Phillipson</surname><given-names>J. D.</given-names></name></person-group><source><italic>Herbal Medicines: A Guide for Health-Care Professionals</italic></source><year>1996</year><publisher-loc>London, UK</publisher-loc><publisher-name>The Pharmaceutical Press</publisher-name></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Speroni</surname><given-names>E.</given-names></name><name><surname>Cervellati</surname><given-names>R.</given-names></name><name><surname>Govoni</surname><given-names>P.</given-names></name><name><surname>Guizzardi</surname><given-names>S.</given-names></name><name><surname>Renzulli</surname><given-names>C.</given-names></name><name><surname>Guerra</surname><given-names>M. C.</given-names></name></person-group><article-title>Efficacy of different <italic>Cynara scolymus</italic> preparations on liver complaints</article-title><source><italic>Journal of Ethnopharmacology</italic></source><year>2003</year><volume>86</volume><issue>2-3</issue><fpage>203</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1016/s0378-8741(03)00076-x</pub-id><pub-id pub-id-type="other">2-s2.0-0037625630</pub-id><pub-id pub-id-type="pmid">12738088</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Lo</surname><given-names>R.</given-names></name></person-group><article-title>Phenolic compounds from the leaf extract of artichoke (<italic>Cynara scolymus</italic> L.) and their antimicrobial activities</article-title><source><italic>Journal of Agricultural and Food Chemistry</italic></source><year>2004</year><volume>52</volume><issue>24</issue><fpage>7272</fpage><lpage>7278</lpage><pub-id pub-id-type="doi">10.1021/jf0490192</pub-id><pub-id pub-id-type="other">2-s2.0-9344265790</pub-id><pub-id pub-id-type="pmid">15563206</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>K&#x000fc;sk&#x000fc;-Kiraz</surname><given-names>Z.</given-names></name><name><surname>Mehmet&#x000e7;ik</surname><given-names>G.</given-names></name><name><surname>Dogru-Abbasoglu</surname><given-names>S.</given-names></name><name><surname>Uysal</surname><given-names>M.</given-names></name></person-group><article-title>Artichoke leaf extract reduces oxidative stress and lipoprotein dyshomeostasis in rats fed on high cholesterol diet</article-title><source><italic>Phytotherapy Research</italic></source><year>2010</year><volume>24</volume><issue>4</issue><fpage>565</fpage><lpage>570</lpage><pub-id pub-id-type="doi">10.1002/ptr.2985</pub-id><pub-id pub-id-type="other">2-s2.0-77951592404</pub-id><pub-id pub-id-type="pmid">19777605</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zapolska-Downar</surname><given-names>D.</given-names></name><name><surname>Zapolski-Downar</surname><given-names>A.</given-names></name><name><surname>Naruszewicz</surname><given-names>M.</given-names></name><name><surname>Siennicka</surname><given-names>A.</given-names></name><name><surname>Krasnodbska</surname><given-names>B.</given-names></name><name><surname>Kolodziej</surname><given-names>B.</given-names></name></person-group><article-title>Protective properties of artichoke (<italic>Cynara scolymus</italic>) against oxidative stress induced in cultured endothelial cells and monocytes</article-title><source><italic>Life Sciences</italic></source><year>2002</year><volume>71</volume><issue>24</issue><fpage>2897</fpage><lpage>2908</lpage><pub-id pub-id-type="doi">10.1016/s0024-3205(02)02136-7</pub-id><pub-id pub-id-type="other">2-s2.0-0036836936</pub-id><pub-id pub-id-type="pmid">12377270</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jim&#x000e9;nez-Escrig</surname><given-names>A.</given-names></name><name><surname>Dragsted</surname><given-names>L. O.</given-names></name><name><surname>Daneshvar</surname><given-names>B.</given-names></name><name><surname>Pulido</surname><given-names>R.</given-names></name><name><surname>Saura-Calixto</surname><given-names>F.</given-names></name></person-group><article-title>In vitro antioxidant activities of edible artichoke (<italic>Cynara scolymus</italic> L.) and effect on biomarkers of antioxidants in rats</article-title><source><italic>Journal of Agricultural and Food Chemistry</italic></source><year>2003</year><volume>51</volume><issue>18</issue><fpage>5540</fpage><lpage>5545</lpage><pub-id pub-id-type="doi">10.1021/jf030047e</pub-id><pub-id pub-id-type="other">2-s2.0-0042012842</pub-id><pub-id pub-id-type="pmid">12926911</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reitman</surname><given-names>S.</given-names></name><name><surname>Frankel</surname><given-names>S.</given-names></name></person-group><article-title>Colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases</article-title><source><italic>American Journal of Clinical Pathology</italic></source><year>1957</year><volume>28</volume><issue>1</issue><fpage>56</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1093/ajcp/28.1.56</pub-id><pub-id pub-id-type="pmid">13458125</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allain</surname><given-names>C. C.</given-names></name><name><surname>Poon</surname><given-names>L. S.</given-names></name><name><surname>Chan</surname><given-names>C. S.</given-names></name><name><surname>Richmond</surname><given-names>W.</given-names></name><name><surname>Fu</surname><given-names>P. C.</given-names></name></person-group><article-title>Enzymatic determination of total serum cholesterol</article-title><source><italic>Clinical Chemistry</italic></source><year>1974</year><volume>20</volume><fpage>470</fpage><lpage>475</lpage><pub-id pub-id-type="pmid">4818200</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Assmann</surname><given-names>G.</given-names></name><name><surname>Jabs</surname><given-names>H.-U.</given-names></name><name><surname>Kohnert</surname><given-names>U.</given-names></name><name><surname>Nolte</surname><given-names>W.</given-names></name><name><surname>Schriewer</surname><given-names>H.</given-names></name></person-group><article-title>LDL-cholesterol determination in blood serum following precipitation of LDL with polyvinylsulfate</article-title><source><italic>Clinica Chimica Acta</italic></source><year>1984</year><volume>140</volume><issue>1</issue><fpage>77</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/0009-8981(84)90153-0</pub-id><pub-id pub-id-type="other">2-s2.0-0021257793</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Virella</surname><given-names>M. F.</given-names></name><name><surname>Stone</surname><given-names>P.</given-names></name><name><surname>Elli</surname><given-names>S.</given-names></name><name><surname>Golwell</surname><given-names>J. A.</given-names></name></person-group><article-title>Cholesterol determination in HDL-chol separated by three different methods</article-title><source><italic>Clinical Chemistry</italic></source><year>1977</year><volume>23</volume><issue>5</issue><fpage>882</fpage><lpage>884</lpage><pub-id pub-id-type="pmid">192488</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fossati</surname><given-names>P.</given-names></name><name><surname>Prencipe</surname><given-names>L.</given-names></name></person-group><article-title>Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide</article-title><source><italic>Clinical Chemistry</italic></source><year>1982</year><volume>28</volume><issue>10</issue><fpage>2077</fpage><lpage>2080</lpage><pub-id pub-id-type="other">2-s2.0-0019949179</pub-id><pub-id pub-id-type="pmid">6812986</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naik</surname><given-names>S. R.</given-names></name><name><surname>Panda</surname><given-names>V. S.</given-names></name></person-group><article-title>Antioxidant and hepatoprotective effects of Ginkgo biloba phytosomes in carbon tetrachloride-induced liver injury in rodents</article-title><source><italic>Liver International</italic></source><year>2007</year><volume>27</volume><issue>3</issue><fpage>393</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1111/j.1478-3231.2007.01463.x</pub-id><pub-id pub-id-type="other">2-s2.0-33947286256</pub-id><pub-id pub-id-type="pmid">17355462</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azzini</surname><given-names>E.</given-names></name><name><surname>Bugianesi</surname><given-names>R.</given-names></name><name><surname>Romano</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Absorption and metabolism of bioactive molecules after oral consumption of cooked edible heads of <italic>Cynara scolymus</italic> L. (Cultivar Violetto di Provenza) in human subjects: a pilot study</article-title><source><italic>The British Journal of Nutrition</italic></source><year>2007</year><volume>97</volume><issue>5</issue><fpage>963</fpage><lpage>969</lpage><pub-id pub-id-type="doi">10.1017/s0007114507617218</pub-id><pub-id pub-id-type="pmid">17408528</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wittemer</surname><given-names>S. M.</given-names></name><name><surname>Ploch</surname><given-names>M.</given-names></name><name><surname>Windeck</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of Artichoke leaf extracts in humans</article-title><source><italic>Phytomedicine</italic></source><year>2005</year><volume>12</volume><issue>1-2</issue><fpage>28</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2003.11.002</pub-id><pub-id pub-id-type="other">2-s2.0-12944324240</pub-id><pub-id pub-id-type="pmid">15693705</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sch&#x000fc;tz</surname><given-names>K.</given-names></name><name><surname>Kammerer</surname><given-names>D.</given-names></name><name><surname>Carle</surname><given-names>R.</given-names></name><name><surname>Schieber</surname><given-names>A.</given-names></name></person-group><article-title>Identification and quantification of caffeoylquinic acids and flavonoids from artichoke (<italic>Cynara scolymus</italic> L.) heads, juice, and pomace by HPLC-DAD-ESI/MSn</article-title><source><italic>Journal of Agricultural and Food Chemistry</italic></source><year>2004</year><volume>52</volume><issue>13</issue><fpage>4090</fpage><lpage>4096</lpage><pub-id pub-id-type="doi">10.1021/jf049625x</pub-id><pub-id pub-id-type="other">2-s2.0-3042567137</pub-id><pub-id pub-id-type="pmid">15212452</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gebhardt</surname><given-names>R.</given-names></name></person-group><article-title>Inhibition of cholesterol biosynthesis in primary cultured rat hepatocytes by artichoke (<italic>Cynara scolymus</italic> L) extracts</article-title><source><italic>Journal of Pharmacology and Experimental Therapeutics</italic></source><year>1998</year><volume>286</volume><issue>3</issue><fpage>1122</fpage><lpage>1128</lpage><pub-id pub-id-type="other">2-s2.0-0032160185</pub-id><pub-id pub-id-type="pmid">9732368</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaya</surname><given-names>J.</given-names></name><name><surname>Aviram</surname><given-names>M.</given-names></name></person-group><article-title>Nutritional antioxidants mechanisms of action, analyses of activities and medical applications</article-title><source><italic>Current Medicinal Chemistry-Immunology, Endocrine &#x00026; Metabolic Agents</italic></source><year>2001</year><volume>1</volume><issue>1</issue><fpage>99</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.2174/1568013013359168</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urquiaga</surname><given-names>I.</given-names></name><name><surname>Leighton</surname><given-names>F.</given-names></name></person-group><article-title>Plant polyphenol antioxidants and oxidative stress</article-title><source><italic>Biological Research</italic></source><year>2000</year><volume>33</volume><issue>2</issue><fpage>55</fpage><lpage>64</lpage><pub-id pub-id-type="other">2-s2.0-0002796453</pub-id><pub-id pub-id-type="pmid">15693271</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heidarian</surname><given-names>E.</given-names></name><name><surname>Soofiniya</surname><given-names>Y.</given-names></name><name><surname>Hajihosseini</surname><given-names>R.</given-names></name></person-group><article-title>The effect of aerial part of <italic>Cynara scolymus</italic> extract on the hyperlipidemia, plasma antioxidant capacity, and superoxide dismutase activity in diabetic rats</article-title><source><italic>Journal of Shahrekord University of Medical Sciences</italic></source><year>2013</year><volume>13</volume><issue>5</issue><fpage>1</fpage><lpage>10</lpage></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metwally</surname><given-names>N. S.</given-names></name><name><surname>Kholeif</surname><given-names>T. E.</given-names></name><name><surname>Ghanem</surname><given-names>K. Z.</given-names></name><name><surname>Farrag</surname><given-names>A. R. H.</given-names></name><name><surname>Ammar</surname><given-names>N. M.</given-names></name><name><surname>Abdel-Hamid</surname><given-names>A. H. Z.</given-names></name></person-group><article-title>The protective effects of fish oil and artichoke on hepatocellular carcinoma in rats</article-title><source><italic>European Review for Medical and Pharmacological Sciences</italic></source><year>2011</year><volume>15</volume><issue>12</issue><fpage>1429</fpage><lpage>1444</lpage><pub-id pub-id-type="other">2-s2.0-84857028309</pub-id><pub-id pub-id-type="pmid">22288304</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehmet&#x000e7;ik</surname><given-names>G.</given-names></name><name><surname>&#x000d6;zdemirler</surname><given-names>G.</given-names></name><name><surname>Ko&#x000e7;ak-Toker</surname><given-names>N.</given-names></name><name><surname>&#x000c7;evikba&#x0015f;</surname><given-names>U.</given-names></name><name><surname>Uysal</surname><given-names>M.</given-names></name></person-group><article-title>Effect of pretreatment with artichoke extract on carbon tetrachloride-induced liver injury and oxidative stress</article-title><source><italic>Experimental and Toxicologic Pathology</italic></source><year>2008</year><volume>60</volume><issue>6</issue><fpage>475</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1016/j.etp.2008.04.014</pub-id><pub-id pub-id-type="pmid">18583118</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miccadei</surname><given-names>S.</given-names></name><name><surname>Venere</surname><given-names>D. D.</given-names></name><name><surname>Cardinali</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Antioxidative and apoptotic properties of polyphenolic extracts from edible part of artichoke (<italic>Cynara scolymus</italic> L.) on cultured rat hepatocytes and on human hepatoma cells</article-title><source><italic>Nutrition and Cancer</italic></source><year>2008</year><volume>60</volume><issue>2</issue><fpage>276</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1080/01635580801891583</pub-id><pub-id pub-id-type="other">2-s2.0-41349115088</pub-id><pub-id pub-id-type="pmid">18444161</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Safaa</surname><given-names>M.</given-names></name><name><surname>Hanaa</surname><given-names>A.</given-names></name><name><surname>Abdel</surname><given-names>F.</given-names></name><name><surname>Nahila</surname><given-names>A.</given-names></name><name><surname>Abdelaaty</surname><given-names>S.</given-names></name></person-group><article-title>Cynara scolymus for relieving on nonalcoholic steatohepatitis induced in rat</article-title><source><italic>International Journal of Pharmacy and Pharmaceutical Sciences</italic></source><year>2013</year><volume>5</volume><issue>1</issue><fpage>57</fpage><lpage>66</lpage></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huber</surname><given-names>R.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>M.</given-names></name><name><surname>Naumann</surname><given-names>J.</given-names></name><name><surname>Schenk</surname><given-names>T.</given-names></name><name><surname>L&#x000fc;dtke</surname><given-names>R.</given-names></name></person-group><article-title>Artichoke leave extract for chronic hepatitis C&#x02014;a pilot study</article-title><source><italic>Phytomedicine</italic></source><year>2009</year><volume>16</volume><issue>9</issue><fpage>801</fpage><lpage>804</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2009.03.007</pub-id><pub-id pub-id-type="other">2-s2.0-67650559363</pub-id><pub-id pub-id-type="pmid">19427774</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pittler</surname><given-names>M. H.</given-names></name><name><surname>Thompson</surname><given-names>C. J.</given-names></name><name><surname>Ernst</surname><given-names>E.</given-names></name></person-group><article-title>Artichoke leaf extract for treating hypercholesterolaemia</article-title><source><italic>The Cochrane Database of Systematic Reviews</italic></source><year>2009</year><issue>4</issue><pub-id pub-id-type="publisher-id">CD003335</pub-id><pub-id pub-id-type="doi">10.1002/14651858.CD003335.pub2</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimoda</surname><given-names>H.</given-names></name><name><surname>Ninomiya</surname><given-names>K.</given-names></name><name><surname>Nishida</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Anti-hyperlipidemic sesquiterpenes and new sesquiterpene glycosides from the leaves of artichoke (<italic>Cynara scolymus</italic> L.): structure requirement and mode of action</article-title><source><italic>Bioorganic and Medicinal Chemistry Letters</italic></source><year>2003</year><volume>13</volume><issue>2</issue><fpage>223</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1016/s0960-894x(02)00889-2</pub-id><pub-id pub-id-type="other">2-s2.0-0037212107</pub-id><pub-id pub-id-type="pmid">12482428</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiang</surname><given-names>Z.</given-names></name><name><surname>Lee</surname><given-names>S.-O.</given-names></name><name><surname>Ye</surname><given-names>Z.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Hendrich</surname><given-names>S.</given-names></name></person-group><article-title>Artichoke extract lowered plasma cholesterol and increased fecal bile acids in Golden Syrian hamsters</article-title><source><italic>Phytotherapy Research</italic></source><year>2012</year><volume>26</volume><issue>7</issue><fpage>1048</fpage><lpage>1052</lpage><pub-id pub-id-type="doi">10.1002/ptr.3698</pub-id><pub-id pub-id-type="other">2-s2.0-84863716129</pub-id><pub-id pub-id-type="pmid">22183827</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arion</surname><given-names>W. J.</given-names></name><name><surname>Canfield</surname><given-names>W. K.</given-names></name><name><surname>Ramos</surname><given-names>F. C.</given-names></name><etal/></person-group><article-title>Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase</article-title><source><italic>Archives of Biochemistry and Biophysics</italic></source><year>1997</year><volume>339</volume><issue>2</issue><fpage>315</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1006/abbi.1996.9874</pub-id><pub-id pub-id-type="other">2-s2.0-0031569345</pub-id><pub-id pub-id-type="pmid">9056264</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cetto</surname><given-names>A. A.</given-names></name><name><surname>Wiedenfeld</surname><given-names>H.</given-names></name></person-group><article-title>Hypoglycemic effect of <italic>Cecropia obtusifolia</italic> on streptozotocin diabetic rats</article-title><source><italic>Ethnopharmacology</italic></source><year>2001</year><volume>78</volume><issue>2-3</issue><fpage>145</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1016/s0378-8741(01)00335-x</pub-id><pub-id pub-id-type="pmid">11694359</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simonen</surname><given-names>P.</given-names></name><name><surname>Kotronen</surname><given-names>A.</given-names></name><name><surname>Hallikainen</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity</article-title><source><italic>Journal of Hepatology</italic></source><year>2011</year><volume>54</volume><issue>1</issue><fpage>153</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2010.05.037</pub-id><pub-id pub-id-type="other">2-s2.0-78649632998</pub-id><pub-id pub-id-type="pmid">20947198</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>M. S.</given-names></name><name><surname>Goldstein</surname><given-names>J. L.</given-names></name></person-group><article-title>The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor</article-title><source><italic>Cell</italic></source><year>1997</year><volume>89</volume><issue>3</issue><fpage>331</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)80213-5</pub-id><pub-id pub-id-type="other">2-s2.0-0030941803</pub-id><pub-id pub-id-type="pmid">9150132</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikonen</surname><given-names>E.</given-names></name></person-group><article-title>Cellular cholesterol trafficking and compartmentalization</article-title><source><italic>Nature Reviews Molecular Cell Biology</italic></source><year>2008</year><volume>9</volume><issue>2</issue><fpage>125</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1038/nrm2336</pub-id><pub-id pub-id-type="other">2-s2.0-38549141572</pub-id><pub-id pub-id-type="pmid">18216769</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caballero</surname><given-names>F.</given-names></name><name><surname>Fernandez</surname><given-names>A.</given-names></name><name><surname>De Lacy</surname><given-names>A. M.</given-names></name><name><surname>Fernandez-Checa</surname><given-names>J. C.</given-names></name><name><surname>Caballeria</surname><given-names>J.</given-names></name><name><surname>Garcia-Ruiz</surname><given-names>C.</given-names></name></person-group><article-title>Enhanced free cholesterol SREBP-2 and StAR expression in human NASH</article-title><source><italic>Journal of Hepatology</italic></source><year>2009</year><volume>50</volume><issue>4</issue><fpage>789</fpage><lpage>796</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2008.12.016</pub-id><pub-id pub-id-type="pmid">19231010</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Changes in study biomarkers in intervention and placebo groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Marker </th><th align="center" colspan="3" rowspan="1">Intervention group</th><th align="center" colspan="3" rowspan="1">Placebo group</th><th align="center" rowspan="2" colspan="1">Intergroup difference</th></tr><tr><th align="center" rowspan="1" colspan="1">Before</th><th align="center" rowspan="1" colspan="1">After</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic> value</th><th align="center" rowspan="1" colspan="1">Before</th><th align="center" rowspan="1" colspan="1">After</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Weight (kg)</td><td align="center" rowspan="1" colspan="1">83.90 &#x000b1; 15.83</td><td align="center" rowspan="1" colspan="1">79.28 &#x000b1; 14.25</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">81.81 &#x000b1; 14.25</td><td align="center" rowspan="1" colspan="1">77.05 &#x000b1; 14.83</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">0.859</td></tr><tr><td align="left" rowspan="1" colspan="1">ALT (mg/dL)</td><td align="center" rowspan="1" colspan="1">81.77 &#x000b1; 38.73</td><td align="center" rowspan="1" colspan="1">38.40 &#x000b1; 14.15</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">74.13 &#x000b1; 23.61</td><td align="center" rowspan="1" colspan="1">64.07 &#x000b1; 20.36</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">AST (mg/dL)</td><td align="center" rowspan="1" colspan="1">45.53 &#x000b1; 13.78</td><td align="center" rowspan="1" colspan="1">24.60 &#x000b1; 7.43</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">44.50 &#x000b1; 9.82</td><td align="center" rowspan="1" colspan="1">39.60 &#x000b1; 10.41</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">FBS (mg/dL)</td><td align="center" rowspan="1" colspan="1">108.07 &#x000b1; 28.90</td><td align="center" rowspan="1" colspan="1">97.60 &#x000b1; 14.50</td><td align="center" rowspan="1" colspan="1">0.029</td><td align="center" rowspan="1" colspan="1">107.43 &#x000b1; 18.48</td><td align="center" rowspan="1" colspan="1">102.57 &#x000b1; 10.78</td><td align="center" rowspan="1" colspan="1">0.096</td><td align="center" rowspan="1" colspan="1">0.302</td></tr><tr><td align="left" rowspan="1" colspan="1">Chol (mg/dL)</td><td align="center" rowspan="1" colspan="1">206.47 &#x000b1; 31.20</td><td align="center" rowspan="1" colspan="1">182.87 &#x000b1; 34.64</td><td align="center" rowspan="1" colspan="1">0.001</td><td align="center" rowspan="1" colspan="1">213.67 &#x000b1; 48.48</td><td align="center" rowspan="1" colspan="1">211.63 &#x000b1; 48.96</td><td align="center" rowspan="1" colspan="1">0.686</td><td align="center" rowspan="1" colspan="1">0.008</td></tr><tr><td align="left" rowspan="1" colspan="1">LDL (mg/dL)</td><td align="center" rowspan="1" colspan="1">122.14 &#x000b1; 30.42</td><td align="center" rowspan="1" colspan="1">108.12 &#x000b1; 32.36</td><td align="center" rowspan="1" colspan="1">0.039</td><td align="center" rowspan="1" colspan="1">116.09 &#x000b1; 29.38</td><td align="center" rowspan="1" colspan="1">113.23 &#x000b1; 31.79</td><td align="center" rowspan="1" colspan="1">0.659</td><td align="center" rowspan="1" colspan="1">0.120</td></tr><tr><td align="left" rowspan="1" colspan="1">HDL (mg/dL)</td><td align="center" rowspan="1" colspan="1">45.87 &#x000b1; 10.46</td><td align="center" rowspan="1" colspan="1">43.33 &#x000b1; 8.20</td><td align="center" rowspan="1" colspan="1">0.129</td><td align="center" rowspan="1" colspan="1">45.50 &#x000b1; 7.50</td><td align="center" rowspan="1" colspan="1">44.87 &#x000b1; 6.10</td><td align="center" rowspan="1" colspan="1">0.689</td><td align="center" rowspan="1" colspan="1">0.403</td></tr><tr><td align="left" rowspan="1" colspan="1">TG (mg/dL)</td><td align="center" rowspan="1" colspan="1">193.37 &#x000b1; 86.03</td><td align="center" rowspan="1" colspan="1">154.50 &#x000b1; 84.93</td><td align="center" rowspan="1" colspan="1">0.011</td><td align="center" rowspan="1" colspan="1">179.87 &#x000b1; 45.67</td><td align="center" rowspan="1" colspan="1">184.23 &#x000b1; 57.83</td><td align="center" rowspan="1" colspan="1">0.659</td><td align="center" rowspan="1" colspan="1">0.016</td></tr><tr><td align="left" rowspan="1" colspan="1">SBP (mg/dL)</td><td align="center" rowspan="1" colspan="1">132.70 &#x000b1; 13.55</td><td align="center" rowspan="1" colspan="1">126.57 &#x000b1; 8.54</td><td align="center" rowspan="1" colspan="1">0.004</td><td align="center" rowspan="1" colspan="1">130.23 &#x000b1; 10.34</td><td align="center" rowspan="1" colspan="1">128.20 &#x000b1; 6.62</td><td align="center" rowspan="1" colspan="1">0.044</td><td align="center" rowspan="1" colspan="1">0.070</td></tr><tr><td align="left" rowspan="1" colspan="1">DBP (mg/dL)</td><td align="center" rowspan="1" colspan="1">80.00 &#x000b1; 9.21</td><td align="center" rowspan="1" colspan="1">79.03 &#x000b1; 6.89</td><td align="center" rowspan="1" colspan="1">0.578</td><td align="center" rowspan="1" colspan="1">80.87 &#x000b1; 8.52</td><td align="center" rowspan="1" colspan="1">81.63 &#x000b1; 7.31</td><td align="center" rowspan="1" colspan="1">0.504</td><td align="center" rowspan="1" colspan="1">0.403</td></tr></tbody></table></table-wrap><table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Multivariate linear regression models for determining the role of <italic>Cynara scolymus</italic> use on changes in liver enzymes and lipid profile.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Marker </th><th align="center" rowspan="1" colspan="1">Variable</th><th align="center" rowspan="1" colspan="1">Beta</th><th align="center" rowspan="1" colspan="1">95% confidence interval</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="3" colspan="1">ALT change</td><td align="center" rowspan="1" colspan="1">Artichoke use</td><td align="center" rowspan="1" colspan="1">&#x02212;31.365</td><td align="center" rowspan="1" colspan="1">&#x02212;45.201 to &#x02212;17.528</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="center" rowspan="1" colspan="1">Male sex</td><td align="center" rowspan="1" colspan="1">&#x02212;0.634</td><td align="center" rowspan="1" colspan="1">&#x02212;16.252 to 14.983</td><td align="center" rowspan="1" colspan="1">0.935</td></tr><tr><td align="center" rowspan="1" colspan="1">Age</td><td align="center" rowspan="1" colspan="1">&#x02212;0.754</td><td align="center" rowspan="1" colspan="1">&#x02212;1.434 to &#x02212;0.074</td><td align="center" rowspan="1" colspan="1">0.030</td></tr><tr><td align="center" colspan="5" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="3" colspan="1">AST change</td><td align="center" rowspan="1" colspan="1">Artichoke use</td><td align="center" rowspan="1" colspan="1">&#x02212;16.041</td><td align="center" rowspan="1" colspan="1">&#x02212;21.405 to &#x02212;10.677</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="center" rowspan="1" colspan="1">Male sex</td><td align="center" rowspan="1" colspan="1">&#x02212;2.995</td><td align="center" rowspan="1" colspan="1">&#x02212;9.049 to 3.060</td><td align="center" rowspan="1" colspan="1">0.326</td></tr><tr><td align="center" rowspan="1" colspan="1">Age</td><td align="center" rowspan="1" colspan="1">0.003</td><td align="center" rowspan="1" colspan="1">&#x02212;0.261 to 0.266</td><td align="center" rowspan="1" colspan="1">0.983</td></tr><tr><td align="center" colspan="5" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="3" colspan="1">Chol change</td><td align="center" rowspan="1" colspan="1">Artichoke use</td><td align="center" rowspan="1" colspan="1">&#x02212;21.673</td><td align="center" rowspan="1" colspan="1">&#x02212;37.245 to &#x02212;6.101</td><td align="center" rowspan="1" colspan="1">0.007</td></tr><tr><td align="center" rowspan="1" colspan="1">Male sex</td><td align="center" rowspan="1" colspan="1">&#x02212;17.072</td><td align="center" rowspan="1" colspan="1">&#x02212;34.648 to 0.505</td><td align="center" rowspan="1" colspan="1">0.057</td></tr><tr><td align="center" rowspan="1" colspan="1">Age</td><td align="center" rowspan="1" colspan="1">0.041</td><td align="center" rowspan="1" colspan="1">&#x02212;0.723 to 0.806</td><td align="center" rowspan="1" colspan="1">0.914</td></tr><tr><td align="center" colspan="5" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="3" colspan="1">TG change</td><td align="center" rowspan="1" colspan="1">Artichoke use</td><td align="center" rowspan="1" colspan="1">&#x02212;41.960</td><td align="center" rowspan="1" colspan="1">&#x02212;76.613 to &#x02212;7.307</td><td align="center" rowspan="1" colspan="1">0.019</td></tr><tr><td align="center" rowspan="1" colspan="1">Male sex</td><td align="center" rowspan="1" colspan="1">&#x02212;28.315</td><td align="center" rowspan="1" colspan="1">&#x02212;67.428 to 10.798</td><td align="center" rowspan="1" colspan="1">0.153</td></tr><tr><td align="center" rowspan="1" colspan="1">Age</td><td align="center" rowspan="1" colspan="1">&#x02212;0.496</td><td align="center" rowspan="1" colspan="1">&#x02212;2.198 to 1.206</td><td align="center" rowspan="1" colspan="1">0.562</td></tr></tbody></table></table-wrap></floats-group></article>